About this trial
Unsafe patient care remains a major contributor to global morbidity and mortality. In surgical wards, postoperative patients are typically monitored intermittently using the National Early Warning Score (NEWS-2), leaving periods during which clinical deterioration may go undetected. Continuous vital sign monitoring (CVSM) using wearable sensors offers the potential for earlier identification of deterioration compared with intermittent assessments.
CVSM was introduced in a hospital ward as part of a hospital-initiated pilot implementation and is used alongside standard monitoring with NEWS-2. The purpose of the study is to evaluate this implementation.
This observational study uses a pragmatic, quasi-experimental, multi-method, longitudinal design. The overall aims of the study are to evaluate the impact of CVSM implementation on patient outcomes, to explore healthcare professionals' perceptions of patient safety culture, turnover intention and pleasure of work, and to describe their experiences with implementation.
Eligibility criteria
Qualifiers
Patients aged 18 years or older admitted to the gastro-surgical ward.
Healthcare professionals aged 18 years or older employed in the participating wards for survey participation.
Nursing staff with at least 6 months of work experience and experience using CVSM for participation in qualitative focus group interviews.
Disqualifiers
Patients with delirium.
Patients with cognitive impairment interfering with sensor use.
Patients who decline participation.
Patients with allergy to electrode adhesives.
Trial design
Treatments tested in this trial
- Continuous Vital Sign Monitoring (CVSM)
Treatment groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Sponsors and collaborators
University Hospital, Akershus
Lead sponsor
Norwegian University of Science and Technology
Collaborator